Research / ALSN / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-118639 General Corporate
Debt relative to revenue 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
293.08% · OPTIONAL · VALID
Capex intensity 53th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.37% · OPTIONAL · VALID
Operating cash generation 94th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
29.85% · OPTIONAL · VALID
Revenue growth 54th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
11.96% · CORE · VALID
Inventory pressure 94th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
39.56% · OPTIONAL · VALID
Gross margin 65th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
48.06% · CORE · VALID
Operating margin 94th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
31.55% · CORE · VALID
R&D intensity 24th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.19% · OPTIONAL · VALID
SBC intensity 53th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.73% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 296.20%
Current 293.08%
Delta -3.12% Capex Intensity Increased
Previous 2.57%
Current 4.37%
Delta 1.80% Cash Generation Increased
Previous 20.96%
Current 29.85%
Delta 8.90% Growth Increased
Previous 4.21%
Current 11.96%
Delta 7.74% Inventory Pressure Increased
Previous 37.13%
Current 39.56%
Delta 2.43% Margin Decreased
Previous 48.28%
Current 48.06%
Delta -0.23% Profitability Decreased
Previous 32.23%
Current 31.55%
Delta -0.68% R And D Intensity Increased
Previous 6.00%
Current 6.19%
Delta 0.18% Sbc Intensity Decreased
Previous 0.98%
Current 0.73%
Delta -0.25% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.